{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:05:25Z","timestamp":1793070325895,"version":"4.5.0"},"reference-count":107,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T00:00:00Z","timestamp":1657497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T00:00:00Z","timestamp":1657497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-022-01388-9","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T04:34:01Z","timestamp":1657600441000},"page":"2191-2204","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["On the importance of the interplay of residual renal function with clinical outcomes in end-stage kidney disease"],"prefix":"10.1093","volume":"35","author":[{"given":"Cem","family":"Tanriover","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu","family":"Ucku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8152-5471","authenticated-orcid":false,"given":"Carlo","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2235-0103","authenticated-orcid":false,"given":"Katherine R.","family":"Tuttle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1297-0675","authenticated-orcid":false,"given":"Mehmet","family":"Kanbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,7,11]]},"reference":[{"key":"1388_CR1","unstructured":"Prevention CfDCa. Chronic Kidney Disease in the United States, 2021 Atlanta, GA: US Department of Health and Human Services; 2021"},{"key":"1388_CR2","unstructured":"Collaboration GCKD. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. 2020."},{"issue":"6","key":"1388_CR3","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1053\/j.ajkd.2009.02.012","volume":"53","author":"J Perl","year":"2009","unstructured":"Perl J, Bargman JM (2009) The importance of residual kidney function for patients on dialysis: a critical review. Am J Kidney Dis 53(6):1068\u20131081","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"1388_CR4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1159\/000503805","volume":"50","author":"T Li","year":"2019","unstructured":"Li T, Wilcox CS, Lipkowitz MS, Gordon-Cappitelli J, Dragoi S (2019) Rationale and strategies for preserving residual kidney function in dialysis patients. Am J Nephrol 50(6):411\u2013421","journal-title":"Am J Nephrol"},{"issue":"10","key":"1388_CR5","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/sj.ki.5000382","volume":"69","author":"AY Wang","year":"2006","unstructured":"Wang AY, Lai KN (2006) The importance of residual renal function in dialysis patients. Kidney Int 69(10):1726\u20131732","journal-title":"Kidney Int"},{"issue":"6","key":"1388_CR6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/1744-9987.12576","volume":"21","author":"P de Sequera","year":"2017","unstructured":"de Sequera P, Corchete E, Bohorquez L, Albalate M, Perez-Garcia R, Alique M et al (2017) Residual renal function in hemodialysis and inflammation. Ther Apher Dial 21(6):592\u2013598","journal-title":"Ther Apher Dial"},{"issue":"1","key":"1388_CR7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000484603","volume":"4","author":"VD Raikou","year":"2018","unstructured":"Raikou VD, Kardalinos V, Kyriaki D (2018) The Relationship of residual renal function with cardiovascular morbidity in hemodialysis patients and the potential role of monocyte chemoattractant protein-1. Kidney Dis (Basel) 4(1):20\u201328","journal-title":"Kidney Dis (Basel)"},{"issue":"2","key":"1388_CR8","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1046\/j.1523-1755.2002.00471.x","volume":"62","author":"AY Wang","year":"2002","unstructured":"Wang AY, Wang M, Woo J, Law MC, Chow KM, Li PK et al (2002) A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int 62(2):639\u2013647","journal-title":"Kidney Int"},{"key":"1388_CR9","doi-asserted-by":"crossref","unstructured":"Lin YC, Peng CC, Chen KC, Chen HH, Fang TC, Sung SY, et al. Effects of cholesterol levels on mortality in patients with long-term peritoneal dialysis based on residual renal function. Nutrients. 2018;10(3).","DOI":"10.3390\/nu10030300"},{"issue":"2","key":"1388_CR10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5414\/CN109064","volume":"90","author":"W Zhou","year":"2018","unstructured":"Zhou W, Hu W, Han G, Wang H, Zhang J, Mei C (2018) The impact of residual renal function on quality of life in patients with peritoneal dialysis. Clin Nephrol 90(2):106\u2013111","journal-title":"Clin Nephrol"},{"issue":"6","key":"1388_CR11","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1053\/j.ajkd.2017.09.010","volume":"71","author":"Y Obi","year":"2018","unstructured":"Obi Y, Streja E, Mehrotra R, Rivara MB, Rhee CM, Soohoo M et al (2018) Impact of obesity on modality longevity, residual kidney function, peritonitis, and survival among incident peritoneal dialysis patients. Am J Kidney Dis 71(6):802\u2013813","journal-title":"Am J Kidney Dis"},{"key":"1388_CR12","doi-asserted-by":"crossref","unstructured":"Cupisti A, Bolasco P, D'Alessandro C, Giannese D, Sabatino A, Fiaccadori E. Protection of residual renal function and nutritional treatment: first step strategy for reduction of uremic toxins in end-stage kidney disease patients. Toxins (Basel). 2021;13(4).","DOI":"10.3390\/toxins13040289"},{"issue":"3","key":"1388_CR13","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/sdi.12302","volume":"28","author":"N Patel","year":"2015","unstructured":"Patel N, Hu SL (2015) Preserving residual renal function in dialysis: what we know. Semin Dial 28(3):250\u2013258","journal-title":"Semin Dial"},{"issue":"6","key":"1388_CR14","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/ckj\/sfaa078","volume":"13","author":"M Kanbay","year":"2020","unstructured":"Kanbay M, Ertuglu LA, Afsar B, Ozdogan E, Siriopol D, Covic A et al (2020) An update review of intradialytic hypotension: concept, risk factors, clinical implications and management. Clin Kidney J 13(6):981\u2013993","journal-title":"Clin Kidney J"},{"issue":"2","key":"1388_CR15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ekir.2021.11.019","volume":"7","author":"MS Cheetham","year":"2022","unstructured":"Cheetham MS, Cho Y, Krishnasamy R, Jain AK, Boudville N, Johnson DW et al (2022) Incremental versus standard (full-dose) peritoneal dialysis. Kidney Int Rep 7(2):165\u2013176","journal-title":"Kidney Int Rep"},{"issue":"2","key":"1388_CR16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1053\/j.ajkd.2016.01.008","volume":"68","author":"Y Obi","year":"2016","unstructured":"Obi Y, Streja E, Rhee CM, Ravel V, Amin AN, Cupisti A et al (2016) Incremental hemodialysis, residual kidney function, and mortality risk in incident dialysis patients: a cohort study. Am J Kidney Dis 68(2):256\u2013265","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1388_CR17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.kint.2016.09.052","volume":"91","author":"J Lowenstein","year":"2017","unstructured":"Lowenstein J, Grantham JJ (2017) Residual renal function: a paradigm shift. Kidney Int 91(3):561\u2013565","journal-title":"Kidney Int"},{"issue":"5","key":"1388_CR18","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.kint.2015.10.011","volume":"89","author":"T Shafi","year":"2016","unstructured":"Shafi T, Michels WM, Levey AS, Inker LA, Dekker FW, Krediet RT et al (2016) Estimating residual kidney function in dialysis patients without urine collection. Kidney Int 89(5):1099\u20131110","journal-title":"Kidney Int"},{"issue":"4","key":"1388_CR19","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/ndt\/gfg147","volume":"18","author":"CJ Konings","year":"2003","unstructured":"Konings CJ, Kooman JP, Schonck M, Struijk DG, Gladziwa U, Hoorntje SJ et al (2003) Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study. Nephrol Dial Transplant 18(4):797\u2013803","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"1388_CR20","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1046\/j.1523-1755.2002.00505.x","volume":"62","author":"MA Jansen","year":"2002","unstructured":"Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT et al (2002) Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 62(3):1046\u20131053","journal-title":"Kidney Int"},{"issue":"1","key":"1388_CR21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11255-012-0346-2","volume":"46","author":"S Liu","year":"2014","unstructured":"Liu S, Diao Z, Zhang D, Ding J, Cui W, Liu W (2014) Preservation of residual renal function by not removing water in new hemodialysis patients: a randomized, controlled study. Int Urol Nephrol 46(1):83\u201390","journal-title":"Int Urol Nephrol"},{"key":"1388_CR22","doi-asserted-by":"crossref","unstructured":"Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol. 1996;7(2):198\u2013207.","DOI":"10.1681\/ASN.V72198"},{"issue":"10","key":"1388_CR23","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1681\/ASN.V12102158","volume":"12","author":"JM Bargman","year":"2001","unstructured":"Bargman JM, Thorpe KE, Churchill DN (2001) Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 12(10):2158\u20132162","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1388_CR24","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1681\/ASN.V1351307","volume":"13","author":"R Paniagua","year":"2002","unstructured":"Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J et al (2002) Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 13(5):1307\u20131320","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1388_CR25","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.ajkd.2005.05.016","volume":"46","author":"B Bammens","year":"2005","unstructured":"Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y (2005) Time profiles of peritoneal and renal clearances of different uremic solutes in incident peritoneal dialysis patients. Am J Kidney Dis 46(3):512\u2013519","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"1388_CR26","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/hy1001.096358","volume":"38","author":"J Blacher","year":"2001","unstructured":"Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM (2001) Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38(4):938\u2013942","journal-title":"Hypertension"},{"issue":"1","key":"1388_CR27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/01.ASN.0000038685.95946.83","volume":"14","author":"AY Wang","year":"2003","unstructured":"Wang AY, Wang M, Woo J, Lam CW, Li PK, Lui SF et al (2003) Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol 14(1):159\u2013168","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1388_CR28","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","volume":"31","author":"GA Block","year":"1998","unstructured":"Block GA, Hulbert-Shearon TE, Levin NW, Port FK (1998) Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31(4):607\u2013617","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"1388_CR29","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1093\/ndt\/gfv414","volume":"31","author":"P Evenepoel","year":"2016","unstructured":"Evenepoel P, Meijers BK, Bammens B, Viaene L, Claes K, Sprangers B et al (2016) Phosphorus metabolism in peritoneal dialysis- and haemodialysis-treated patients. Nephrol Dial Transplant 31(9):1508\u20131514","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"1388_CR30","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/nep.13427","volume":"23","author":"J Kong","year":"2018","unstructured":"Kong J, Davies M, Mount P (2018) The importance of residual kidney function in haemodialysis patients. Nephrol (Carlton) 23(12):1073\u20131080","journal-title":"Nephrol (Carlton)"},{"issue":"4","key":"1388_CR31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3904\/kjim.2014.29.4.489","volume":"29","author":"SM Hur","year":"2014","unstructured":"Hur SM, Ju HY, Park MY, Choi SJ, Kim JK, Hwang SD (2014) Ferritin as a predictor of decline in residual renal function in peritoneal dialysis patients. Korean J Intern Med 29(4):489\u2013497","journal-title":"Korean J Intern Med"},{"issue":"6","key":"1388_CR32","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340(6):448\u2013454","journal-title":"N Engl J Med"},{"issue":"11","key":"1388_CR33","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1093\/ndt\/16.11.2240","volume":"16","author":"SH Chung","year":"2001","unstructured":"Chung SH, Heimb\u00fcrger O, Stenvinkel P, Bergstr\u00f6m J, Lindholm B (2001) Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis. Nephrol Dial Transplant 16(11):2240\u20132245","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"1388_CR34","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.arcmed.2014.07.003","volume":"45","author":"S Palomo-Pi\u00f1\u00f3n","year":"2014","unstructured":"Palomo-Pi\u00f1\u00f3n S, Mora-Villalpando CJ, Del Carmen P-U, Ceballos-Reyes GM, De Jes\u00fas V-G, \u00c1vila-D\u00edaz M et al (2014) Inflammation and myocardial damage markers influence loss of residual renal function in peritoneal dialysis patients. Arch Med Res 45(6):484\u2013488","journal-title":"Arch Med Res"},{"issue":"2","key":"1388_CR35","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1053\/j.ajkd.2010.03.020","volume":"56","author":"T Shafi","year":"2010","unstructured":"Shafi T, Jaar BG, Plantinga LC, Fink NE, Sadler JH, Parekh RS et al (2010) Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis 56(2):348\u2013358","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"1388_CR36","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1185\/030079904X2763","volume":"20","author":"W McClellan","year":"2004","unstructured":"McClellan W, Aronoff SL, Bolton WK, Hood S, Lorber DL, Tang KL et al (2004) The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin 20(9):1501\u20131510","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"1388_CR37","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0272-6386(04)01086-8","volume":"44","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Thamer M, Stefanik K, Kaufman J, Cotter DJ (2004) Epoetin requirements predict mortality in hemodialysis patients. Am J Kidney Dis 44(5):866\u2013876","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1388_CR38","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12882-017-0752-x","volume":"18","author":"EH Louw","year":"2017","unstructured":"Louw EH, Chothia MY (2017) Residual renal function in chronic dialysis is not associated with reduced erythropoietin-stimulating agent dose requirements: a cross-sectional study. BMC Nephrol 18(1):336","journal-title":"BMC Nephrol"},{"issue":"8","key":"1388_CR39","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1093\/ndt\/gfp071","volume":"24","author":"E Vilar","year":"2009","unstructured":"Vilar E, Wellsted D, Chandna SM, Greenwood RN, Farrington K (2009) Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose. Nephrol Dial Transplant 24(8):2502\u20132510","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"1388_CR40","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/ajcn\/76.3.569","volume":"76","author":"AY Wang","year":"2002","unstructured":"Wang AY, Sea MM, Ip R, Law MC, Chow KM, Lui SF et al (2002) Independent effects of residual renal function and dialysis adequacy on dietary micronutrient intakes in patients receiving continuous ambulatory peritoneal dialysis. Am J Clin Nutr 76(3):569\u2013576","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"1388_CR41","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/08860220902963566","volume":"31","author":"PY Yang","year":"2009","unstructured":"Yang PY, Lin JL, Lin-Tan DT, Hsu CW, Yen TH, Chen KH et al (2009) Residual daily urine volume association with inflammation and nutrition status in maintenance hemodialysis patients. Ren Fail 31(6):423\u2013430","journal-title":"Ren Fail"},{"issue":"3","key":"1388_CR42","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s10047-019-01098-3","volume":"22","author":"L Katalinic","year":"2019","unstructured":"Katalinic L, Premuzic V, Basic-Jukic N, Barisic I, Jelakovic B (2019) Hypoproteinemia as a factor in assessing malnutrition and predicting survival on hemodialysis. J Artif Organs 22(3):230\u2013236","journal-title":"J Artif Organs"},{"issue":"12","key":"1388_CR43","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1007\/s11255-016-1428-3","volume":"48","author":"D Sikorska","year":"2016","unstructured":"Sikorska D, Pawlaczyk K, Olewicz-Gawlik A, Czepulis N, Posnik B, Baum E et al (2016) The importance of residual renal function in peritoneal dialysis. Int Urol Nephrol 48(12):2101\u20132108","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"1388_CR44","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jama.291.4.451","volume":"291","author":"Y Liu","year":"2004","unstructured":"Liu Y, Coresh J, Eustace JA, Longenecker JC, Jaar B, Fink NE et al (2004) Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA 291(4):451\u2013459","journal-title":"JAMA"},{"issue":"3","key":"1388_CR45","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/089686089701700306","volume":"17","author":"A Kagan","year":"1997","unstructured":"Kagan A, Elimalech E, Lemer Z, Fink A, Bar-Khayim Y (1997) Residual renal function affects lipid profile in patients undergoing continuous ambulatory peritoneal dialysis. Perit Dial Int 17(3):243\u2013249","journal-title":"Perit Dial Int"},{"key":"1388_CR46","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/914849","volume":"2011","author":"P Cotovio","year":"2011","unstructured":"Cotovio P, Rocha A, Rodrigues A (2011) Peritoneal dialysis in diabetics: there is room for more. Int J Nephrol 2011:914849","journal-title":"Int J Nephrol"},{"issue":"4","key":"1388_CR47","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1053\/j.ajkd.2007.01.018","volume":"49","author":"CC Szeto","year":"2007","unstructured":"Szeto CC, Chow KM, Kwan BC, Chung KY, Leung CB, Li PK (2007) New-onset hyperglycemia in nondiabetic chinese patients started on peritoneal dialysis. Am J Kidney Dis 49(4):524\u2013532","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"1388_CR48","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s11255-015-0987-z","volume":"47","author":"SH Chung","year":"2015","unstructured":"Chung SH, Han DC, Noh H, Jeon JS, Kwon SH, Lindholm B et al (2015) High blood glucose independent of pre-existing diabetic status predicts mortality in patients initiating peritoneal dialysis therapy. Int Urol Nephrol 47(6):1017\u20131024","journal-title":"Int Urol Nephrol"},{"key":"1388_CR49","volume":"2013","author":"MH Yang","year":"2013","unstructured":"Yang MH, Wang HY, Lu CY, Tsai WC, Lin PC, Su SB et al (2013) Proteomic profiling for peritoneal dialysate: differential protein expression in diabetes mellitus. Biomed Res Int 2013:642964","journal-title":"Biomed Res Int"},{"issue":"2","key":"1388_CR50","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.pcad.2018.07.001","volume":"61","author":"N Naderi","year":"2018","unstructured":"Naderi N, Kleine CE, Park C, Hsiung JT, Soohoo M, Tantisattamo E et al (2018) Obesity paradox in advanced kidney disease: from bedside to the bench. Prog Cardiovasc Dis 61(2):168\u2013181","journal-title":"Prog Cardiovasc Dis"},{"issue":"5","key":"1388_CR51","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1681\/ASN.2005111241","volume":"17","author":"HJ Kramer","year":"2006","unstructured":"Kramer HJ, Saranathan A, Luke A, Durazo-Arvizu RA, Guichan C, Hou S et al (2006) Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol 17(5):1453\u20131459","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"1388_CR52","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1053\/j.ajkd.2008.11.027","volume":"53","author":"C Drechsler","year":"2009","unstructured":"Drechsler C, de Mutsert R, Grootendorst DC, Boeschoten EW, Krediet RT, le Cessie S et al (2009) Association of body mass index with decline in residual kidney function after initiation of dialysis. Am J Kidney Dis 53(6):1014\u20131023","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1388_CR53","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1046\/j.1523-1755.1999.00615.x","volume":"56","author":"JD Kopple","year":"1999","unstructured":"Kopple JD, Zhu X, Lew NL, Lowrie EG (1999) Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int 56(3):1136\u20131148","journal-title":"Kidney Int"},{"issue":"9","key":"1388_CR54","volume":"10","author":"JK Kim","year":"2015","unstructured":"Kim JK, Kim YS, Song YR, Kim HJ, Kim SG, Moon SJ (2015) Excessive weight gain during the first year of peritoneal dialysis is associated with inflammation, diabetes mellitus, and a rapid decrease in residual renal function. PLoS One 10(9):e0139033","journal-title":"PLoS One"},{"issue":"2","key":"1388_CR55","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s11906-012-0247-x","volume":"14","author":"E Morales","year":"2012","unstructured":"Morales E, Praga M (2012) The effect of weight loss in obesity and chronic kidney disease. Curr Hypertens Rep 14(2):170\u2013176","journal-title":"Curr Hypertens Rep"},{"issue":"6","key":"1388_CR56","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/ndt\/gfu287","volume":"30","author":"A Sabatino","year":"2015","unstructured":"Sabatino A, Regolisti G, Brusasco I, Cabassi A, Morabito S, Fiaccadori E (2015) Alterations of intestinal barrier and microbiota in chronic kidney disease. Nephrol Dial Transplant 30(6):924\u2013933","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"1388_CR57","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/ki.2011.355","volume":"81","author":"VM Krishnamurthy","year":"2012","unstructured":"Krishnamurthy VM, Wei G, Baird BC, Murtaugh M, Chonchol MB, Raphael KL et al (2012) High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease. Kidney Int 81(3):300\u2013306","journal-title":"Kidney Int"},{"key":"1388_CR58","doi-asserted-by":"crossref","unstructured":"Mafra D, Borges N, Alvarenga L, Esgalhado M, Cardozo L, Lindholm B, et al. Dietary components that may influence the disturbed gut microbiota in chronic kidney disease. Nutrients. 2019;11(3).","DOI":"10.3390\/nu11030496"},{"issue":"2","key":"1388_CR59","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000189334","volume":"74","author":"M Hida","year":"1996","unstructured":"Hida M, Aiba Y, Sawamura S, Suzuki N, Satoh T, Koga Y (1996) Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis. Nephron 74(2):349\u2013355","journal-title":"Nephron"},{"issue":"9","key":"1388_CR60","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1681\/ASN.2013101062","volume":"25","author":"R Vanholder","year":"2014","unstructured":"Vanholder R, Schepers E, Pletinck A, Nagler EV, Glorieux G (2014) The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review. J Am Soc Nephrol 25(9):1897\u20131907","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1388_CR61","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1053\/j.ajkd.2019.08.019","volume":"75","author":"YJ Lee","year":"2020","unstructured":"Lee YJ, Okuda Y, Sy J, Lee YK, Obi Y, Cho S et al (2020) Ultrafiltration rate, residual kidney function, and survival among patients treated with reduced-frequency hemodialysis. Am J Kidney Dis 75(3):342\u2013350","journal-title":"Am J Kidney Dis"},{"key":"1388_CR62","first-page":"180","volume":"22","author":"I Shahab","year":"2006","unstructured":"Shahab I, Khanna R, Nolph KD (2006) Peritoneal dialysis or hemodialysis? A dilemma for the nephrologist. Adv Perit Dial 22:180\u2013185","journal-title":"Adv Perit Dial"},{"issue":"2","key":"1388_CR63","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/1744-9987.12865","volume":"24","author":"H Tsujikawa","year":"2020","unstructured":"Tsujikawa H, Tanaka S, Hara M, Kawai Y, Matsukuma Y, Torisu K et al (2020) Association of lower serum bilirubin with loss of residual kidney function in peritoneal dialysis patients. Ther Apher Dial 24(2):202\u2013207","journal-title":"Ther Apher Dial"},{"issue":"2","key":"1388_CR64","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3747\/pdi.2013.00170","volume":"35","author":"Y Cho","year":"2015","unstructured":"Cho Y, Johnson DW, Vesey DA, Hawley CM, Clarke M, Topley N et al (2015) Utility of urinary biomarkers in predicting loss of residual renal function: the balANZ trial. Perit Dial Int 35(2):159\u2013171","journal-title":"Perit Dial Int"},{"issue":"2","key":"1388_CR65","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3747\/pdi.2013.00075","volume":"35","author":"CC Szeto","year":"2015","unstructured":"Szeto CC, Kwan BC, Chow KM, Chung S, Yu V, Cheng PM et al (2015) Predictors of residual renal function decline in patients undergoing continuous ambulatory peritoneal dialysis. Perit Dial Int 35(2):180\u2013188","journal-title":"Perit Dial Int"},{"issue":"4","key":"1388_CR66","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.echo.2011.11.026","volume":"25","author":"JK Kim","year":"2012","unstructured":"Kim JK, Kim SG, Kim MG, Kim SE, Kim SJ, Kim HJ et al (2012) Left ventricular diastolic dysfunction as a predictor of rapid decline of residual renal function in patients with peritoneal dialysis. J Am Soc Echocardiogr 25(4):411\u2013420","journal-title":"J Am Soc Echocardiogr"},{"key":"1388_CR67","doi-asserted-by":"crossref","unstructured":"Zhang L, Zeng X, Fu P, Wu HM. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients. Cochrane Database Syst Rev. 2014(6):CD009120.","DOI":"10.1002\/14651858.CD009120.pub2"},{"key":"1388_CR68","first-page":"6762029","volume":"2020","author":"L Ding","year":"2020","unstructured":"Ding L, Yang J, Li L, Yang Y (2020) Effects of ACEIs and ARBs on the residual renal function in peritoneal dialysis patients: a meta-analysis of randomized controlled trials. Biomed Res Int 2020:6762029","journal-title":"Biomed Res Int"},{"issue":"1","key":"1388_CR69","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12882-017-0605-7","volume":"18","author":"Y Liu","year":"2017","unstructured":"Liu Y, Ma X, Zheng J, Jia J, Yan T (2017) Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials. BMC Nephrol 18(1):206","journal-title":"BMC Nephrol"},{"issue":"11","key":"1388_CR70","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1093\/ndt\/gfn321","volume":"23","author":"W Fang","year":"2008","unstructured":"Fang W, Oreopoulos DG, Bargman JM (2008) Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis. Nephrol Dial Transplant 23(11):3704\u20133710","journal-title":"Nephrol Dial Transplant"},{"key":"1388_CR71","doi-asserted-by":"crossref","DOI":"10.5402\/2013\/184527","volume":"2013","author":"D Xydakis","year":"2013","unstructured":"Xydakis D, Papadogiannakis A, Sfakianaki M, Kostakis K, Stylianou K, Petrakis I et al (2013) Residual renal function in hemodialysis patients: the role of Angiotensin-converting enzyme inhibitor in its preservation. ISRN Nephrol 2013:184527","journal-title":"ISRN Nephrol"},{"issue":"6","key":"1388_CR72","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1053\/j.ajkd.2014.05.011","volume":"64","author":"KD Kjaergaard","year":"2014","unstructured":"Kjaergaard KD, Peters CD, Jespersen B, Tietze IN, Madsen JK, Pedersen BB et al (2014) Angiotensin blockade and progressive loss of kidney function in hemodialysis patients: a randomized controlled trial. Am J Kidney Dis 64(6):892\u2013901","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1388_CR73","doi-asserted-by":"crossref","first-page":"18103","DOI":"10.1038\/s41598-019-54572-6","volume":"9","author":"KD Yoo","year":"2019","unstructured":"Yoo KD, Kim CT, Kwon S, Lee J, Oh YK, Kang SW et al (2019) Renin angiotensin aldosterone system blockades does not protect residual renal function in patients with hemodialysis at 1 year after dialysis initiation: a prospective observational cohort study. Sci Rep 9(1):18103","journal-title":"Sci Rep"},{"issue":"12","key":"1388_CR74","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1093\/ndt\/gfp511","volume":"25","author":"AK Ahmed","year":"2010","unstructured":"Ahmed AK, Kamath NS, El Kossi M, El Nahas AM (2010) The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease. Nephrol Dial Transplant 25(12):3977\u20133982","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"1388_CR75","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1681\/ASN.2020050682","volume":"32","author":"EL Fu","year":"2021","unstructured":"Fu EL, Evans M, Clase CM, Tomlinson LA, van Diepen M, Dekker FW et al (2021) Stopping renin-angiotensin system inhibitors in patients with advanced CKD and risk of adverse outcomes: a nationwide study. J Am Soc Nephrol 32(2):424\u2013435","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1388_CR76","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1046\/j.1440-1797.2003.00156.x","volume":"8","author":"H Hidaka","year":"2003","unstructured":"Hidaka H, Nakao T (2003) Preservation of residual renal function and factors affecting its decline in patients on peritoneal dialysis. Nephrol (Carlton) 8(4):184\u2013191","journal-title":"Nephrol (Carlton)"},{"issue":"3","key":"1388_CR77","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3747\/pdi.2016.00206","volume":"37","author":"H Htay","year":"2017","unstructured":"Htay H, Cho Y, Pascoe EM, Darssan D, Hawley C, Johnson DW et al (2017) Predictors of residual renal function decline in peritoneal dialysis patients: the. Perit Dial Int 37(3):283\u2013289","journal-title":"Perit Dial Int"},{"issue":"5","key":"1388_CR78","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/sdi.12612","volume":"30","author":"E Ok","year":"2017","unstructured":"Ok E, Levin NW, Asci G, Chazot C, Toz H, Ozkahya M (2017) Interplay of volume, blood pressure, organ ischemia, residual renal function, and diet: certainties and uncertainties with dialytic management. Semin Dial 30(5):420\u2013429","journal-title":"Semin Dial"},{"issue":"5","key":"1388_CR79","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000168471","volume":"12","author":"RW van Olden","year":"1992","unstructured":"van Olden RW, van Meyel JJ, Gerlag PG (1992) Acute and long-term effects of therapy with high-dose furosemide in chronic hemodialysis patients. Am J Nephrol 12(5):351\u2013356","journal-title":"Am J Nephrol"},{"issue":"3","key":"1388_CR80","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1046\/j.1523-1755.2001.0590031128.x","volume":"59","author":"JF Medcalf","year":"2001","unstructured":"Medcalf JF, Harris KP, Walls J (2001) Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis. Kidney Int 59(3):1128\u20131133","journal-title":"Kidney Int"},{"issue":"3","key":"1388_CR81","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1053\/j.ajkd.2006.12.012","volume":"49","author":"JL Bragg-Gresham","year":"2007","unstructured":"Bragg-Gresham JL, Fissell RB, Mason NA, Bailie GR, Gillespie BW, Wizemann V et al (2007) Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS). Am J Kidney Dis 49(3):426\u2013431","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 3","key":"1388_CR82","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1177\/089686080802803s35","volume":"28","author":"CT Liao","year":"2008","unstructured":"Liao CT, Shiao CC, Huang JW, Hung KY, Chuang HF, Chen YM et al (2008) Predictors of faster decline of residual renal function in Taiwanese peritoneal dialysis patients. Perit Dial Int 28(Suppl 3):S191\u2013S195","journal-title":"Perit Dial Int"},{"issue":"1","key":"1388_CR83","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12882-018-0865-x","volume":"19","author":"VM Mokoli","year":"2018","unstructured":"Mokoli VM, Sumaili EK, Lepira FB, Mbutiwi FIN, Makulo JRR, Bukabau JB et al (2018) Factors associated with residual urine volume preservation in patients undergoing hemodialysis for end-stage kidney disease in Kinshasa. BMC Nephrol 19(1):68","journal-title":"BMC Nephrol"},{"issue":"7","key":"1388_CR84","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-048015","volume":"11","author":"W Chen","year":"2021","unstructured":"Chen W, Wang F, Zhao Y, Zhang L, Chen Z, Dai M (2021) Efficacy and safety of furosemide for prevention of intradialytic hypotension in haemodialysis patients: protocol for a multicentre randomised controlled trial. BMJ Open 11(7):e048015","journal-title":"BMJ Open"},{"issue":"5","key":"1388_CR85","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3747\/pdi.2013.00290","volume":"35","author":"T Hiramatsu","year":"2015","unstructured":"Hiramatsu T, Hobo A, Hayasaki T, Kabu K, Furuta S (2015) A Pilot study examining the effects of tolvaptan on residual renal function in peritoneal dialysis for diabetics. Perit Dial Int 35(5):552\u2013558","journal-title":"Perit Dial Int"},{"key":"1388_CR86","first-page":"30","volume":"31","author":"T Hiramatsu","year":"2015","unstructured":"Hiramatsu T, Asai K, Ozeki A, Saka M, Hobo A, Furuta S (2015) The vasopressin 2 receptor antagonist tolvaptan improves nutrition and inflammatory states in peritoneal dialysis patients with diabetes mellitus. Adv Perit Dial 31:30\u201333","journal-title":"Adv Perit Dial"},{"key":"1388_CR87","first-page":"33","volume":"29","author":"T Mori","year":"2013","unstructured":"Mori T, Oba I, Koizumi K, Kodama M, Shimanuki M, Tanno M et al (2013) Beneficial role of tolvaptan in the control of body fluids without reductions in residual renal function in patients undergoing peritoneal dialysis. Adv Perit Dial 29:33\u201337","journal-title":"Adv Perit Dial"},{"issue":"1","key":"1388_CR88","doi-asserted-by":"crossref","first-page":"10105","DOI":"10.1038\/s41598-019-46654-2","volume":"9","author":"Y Lee","year":"2019","unstructured":"Lee Y, Chung SW, Park S, Ryu H, Lee H, Kim DK et al (2019) Incremental peritoneal dialysis may be beneficial for preserving residual renal function compared to full-dose peritoneal dialysis. Sci Rep 9(1):10105","journal-title":"Sci Rep"},{"issue":"10","key":"1388_CR89","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/ndt\/gfv271","volume":"30","author":"TA Golper","year":"2015","unstructured":"Golper TA, Mehrotra R (2015) The intact nephron hypothesis in reverse: an argument to support incremental dialysis. Nephrol Dial Transplant 30(10):1602\u20131604","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"1388_CR90","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s40620-016-0344-z","volume":"29","author":"M Sandrini","year":"2016","unstructured":"Sandrini M, Vizzardi V, Valerio F, Ravera S, Manili L, Zubani R et al (2016) Incremental peritoneal dialysis: a 10 year single-centre experience. J Nephrol 29(6):871\u2013879","journal-title":"J Nephrol"},{"issue":"5","key":"1388_CR91","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s40620-018-00577-9","volume":"32","author":"C Garofalo","year":"2019","unstructured":"Garofalo C, Borrelli S, De Stefano T, Provenzano M, Andreucci M, Cabiddu G et al (2019) Incremental dialysis in ESRD: systematic review and meta-analysis. J Nephrol 32(5):823\u2013836","journal-title":"J Nephrol"},{"issue":"4","key":"1388_CR92","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1053\/j.ajkd.2016.08.019","volume":"69","author":"H Yan","year":"2017","unstructured":"Yan H, Fang W, Lin A, Cao L, Ni Z, Qian J (2017) Three versus 4 daily exchanges and residual kidney function decline in incident CAPD patients: a randomized controlled trial. Am J Kidney Dis 69(4):506\u2013513","journal-title":"Am J Kidney Dis"},{"key":"1388_CR93","doi-asserted-by":"crossref","unstructured":"Cho Y, Johnson DW, Craig JC, Strippoli GF, Badve SV, Wiggins KJ. Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Datab Syst Rev. 2014(3):CD007554.","DOI":"10.1002\/14651858.CD007554.pub2"},{"issue":"13","key":"1388_CR94","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002991","volume":"95","author":"TI Chang","year":"2016","unstructured":"Chang TI, Ryu DR, Yoo TH, Kim HJ, Kang EW, Kim H et al (2016) Effect of Icodextrin solution on the preservation of residual renal function in peritoneal dialysis patients: a randomized controlled study. Med (Baltim) 95(13):e2991","journal-title":"Med (Baltim)"},{"issue":"9","key":"1388_CR95","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.3346\/jkms.2014.29.9.1217","volume":"29","author":"HE Yoon","year":"2014","unstructured":"Yoon HE, Chang YK, Shin SJ, Choi BS, Kim BS, Park CW et al (2014) Benefits of a continuous ambulatory peritoneal dialysis (CAPD) technique with one icodextrin-containing and two biocompatible glucose-containing dialysates for preservation of residual renal function and biocompatibility in incident CAPD patients. J Korean Med Sci 29(9):1217\u20131225","journal-title":"J Korean Med Sci"},{"issue":"7","key":"1388_CR96","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1093\/ndt\/gft050","volume":"28","author":"Y Cho","year":"2013","unstructured":"Cho Y, Johnson DW, Badve S, Craig JC, Strippoli GF, Wiggins KJ (2013) Impact of icodextrin on clinical outcomes in peritoneal dialysis: a systematic review of randomized controlled trials. Nephrol Dial Transplant 28(7):1899\u20131907","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"1388_CR97","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3747\/pdi.2009.00264","volume":"31","author":"H Qi","year":"2011","unstructured":"Qi H, Xu C, Yan H, Ma J (2011) Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: a meta-analysis of randomized controlled trials. Perit Dial Int 31(2):179\u2013188","journal-title":"Perit Dial Int"},{"issue":"2","key":"1388_CR98","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ekir.2019.11.014","volume":"5","author":"M Murea","year":"2020","unstructured":"Murea M, Moossavi S, Garneata L, Kalantar-Zadeh K (2020) Narrative review of incremental hemodialysis. Kidney Int Rep 5(2):135\u2013148","journal-title":"Kidney Int Rep"},{"issue":"1","key":"1388_CR99","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1440-1797.2008.01016.x","volume":"14","author":"YF Lin","year":"2009","unstructured":"Lin YF, Huang JW, Wu MS, Chu TS, Lin SL, Chen YM et al (2009) Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis. Nephrol (Carlton) 14(1):59\u201364","journal-title":"Nephrol (Carlton)"},{"issue":"2","key":"1388_CR100","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000365819","volume":"40","author":"M Zhang","year":"2014","unstructured":"Zhang M, Wang M, Li H, Yu P, Yuan L, Hao C et al (2014) Association of initial twice-weekly hemodialysis treatment with preservation of residual kidney function in ESRD patients. Am J Nephrol 40(2):140\u2013150","journal-title":"Am J Nephrol"},{"issue":"3","key":"1388_CR101","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.kint.2021.07.025","volume":"101","author":"E Vilar","year":"2022","unstructured":"Vilar E, Kaja Kamal RM, Fotheringham J, Busby A, Berdeprado J, Kislowska E et al (2022) A multicenter feasibility randomized controlled trial to assess the impact of incremental versus conventional initiation of hemodialysis on residual kidney function. Kidney Int 101(3):615\u2013625","journal-title":"Kidney Int"},{"key":"1388_CR102","doi-asserted-by":"crossref","unstructured":"Basile C, Casino FG, ERA-EDTA EWGo. Incremental haemodialysis and residual kidney function: more and more observations but no trials. Nephrol Dial Transplant. 2019;34(11):1806\u201311.","DOI":"10.1093\/ndt\/gfz035"},{"issue":"6","key":"1388_CR103","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1053\/j.jrn.2016.01.015","volume":"26","author":"P Bolasco","year":"2016","unstructured":"Bolasco P, Cupisti A, Locatelli F, Caria S, Kalantar-Zadeh K (2016) Dietary management of incremental transition to dialysis therapy: once-weekly hemodialysis combined with low-protein diet. J Ren Nutr 26(6):352\u2013359","journal-title":"J Ren Nutr"},{"key":"1388_CR104","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/1471-2369-15-172","volume":"15","author":"S Caria","year":"2014","unstructured":"Caria S, Cupisti A, Sau G, Bolasco P (2014) The incremental treatment of ESRD: a low-protein diet combined with weekly hemodialysis may be beneficial for selected patients. BMC Nephrol 15:172","journal-title":"BMC Nephrol"},{"key":"1388_CR105","doi-asserted-by":"crossref","unstructured":"Hartmann J. Biocompatible membranes preserve residual renal function in patients undergoing regular hemodialysis. In: Fricke H (eds) American Journal of Kidney Diseases 1997;336\u201373.","DOI":"10.1016\/S0272-6386(97)90281-X"},{"issue":"1","key":"1388_CR106","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1046\/j.1523-1755.2002.00098.x","volume":"61","author":"W McKane","year":"2002","unstructured":"McKane W, Chandna SM, Tattersall JE, Greenwood RN, Farrington K (2002) Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD. Kidney Int 61(1):256\u2013265","journal-title":"Kidney Int"},{"issue":"6","key":"1388_CR107","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/ndt\/gfn089","volume":"23","author":"B Canaud","year":"2008","unstructured":"Canaud B (2008) Residual renal function: the delicate balance between benefits and risks. Nephrol Dial Transplant 23(6):1801\u20131805","journal-title":"Nephrol Dial Transplant"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-022-01388-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-022-01388-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-022-01388-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:54:31Z","timestamp":1777564471000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/35\/9\/2191\/8325640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,11]]},"references-count":107,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1388"],"URL":"https:\/\/doi.org\/10.1007\/s40620-022-01388-9","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,11]]},"assertion":[{"value":"3 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No verbal and written informed consent was necessary for this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}